FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
Página oficial de la convocatoria ↗
The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission. The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission. Permission to submit a conference grant application does not assure funding or funding at the level requested. FDA will not issue a conference grant award unless it can be issued before the conference start date.
Historial de cambios
First seen 28 Sept 2026, last checked 22 Nov 2026. 20 recorded versions.
- 22 Oct 2026 · 08cea67bc935
- 22 Oct 2026 · 711ec973e43d
- 21 Oct 2026 · 018a9140bb24
- 20 Oct 2026 · d6a746df8f8b
- 19 Oct 2026 · dae10cfb30b2
- 18 Oct 2026 · 35f80d20a5b1
- 17 Oct 2026 · 49815ad0408c
- 16 Oct 2026 · a4ba3198ebdc
- 15 Oct 2026 · 3bd12aa41c15
- 14 Oct 2026 · 123715ba41b4
- 13 Oct 2026 · 2c56dd970c53
- 12 Oct 2026 · f762b47fb3a7
- 11 Oct 2026 · a67bc046aa37
- 10 Oct 2026 · 018a9140bb24
- 09 Oct 2026 · a67bc046aa37
- 08 Oct 2026 · a21d84d53e93
- 07 Oct 2026 · 5ce440337a12
- 06 Oct 2026 · 81ead2bf52f3
- 05 Oct 2026 · 11e396326457
- 04 Oct 2026 · bbe1f550b4f7